Tei et al., 2010 - Google Patents
Target visualization by MRI using the avidin/biotin amplification route: synthesis and testing of a biotin–Gd‐DOTA monoamide trimerTei et al., 2010
- Document ID
- 3446319855160990998
- Author
- Tei L
- Barge A
- Geninatti Crich S
- Pagliarin R
- Negri V
- Ramella D
- Cravotto G
- Aime S
- Publication year
- Publication venue
- Chemistry–A European Journal
External Links
Snippet
To design efficient targeting strategies in magnetic resonance (MR) molecular imaging applications, the formation of supramolecular adducts between (strept) avidin ((S) Av) and tribiotinylated Gd‐DOTA‐monoamide complexes (DOTA= 1, 4, 7, 10‐tetraazacyclododecane …
- 230000015572 biosynthetic process 0 title abstract description 12
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Botta et al. | Relaxivity enhancement in macromolecular and nanosized GdIII‐based MRI contrast agents | |
Werner et al. | High‐relaxivity MRI contrast agents: where coordination chemistry meets medical imaging | |
Livramento et al. | A Starburst‐Shaped Heterometallic Compound Incorporating Six Densely Packed Gd3+ Ions | |
Kotek et al. | Lanthanide (III) complexes of novel mixed carboxylic‐phosphorus acid derivatives of diethylenetriamine: a step towards more efficient MRI contrast agents | |
Crich et al. | In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes | |
Šimeček et al. | A Cyclen‐Based Tetraphosphinate Chelator for the Preparation of Radiolabeled Tetrameric Bioconjugates | |
Klemm et al. | Conjugation to biocompatible dendrimers increases lanthanide T2 relaxivity of hydroxypyridinone complexes for magnetic resonance imaging | |
Torres et al. | Supramolecular assembly of an amphiphilic GdIII chelate: Tuning the reorientational correlation time and the water exchange rate | |
Braun et al. | Gain of a 500-fold sensitivity on an intravital MR contrast agent based on an endohedral gadolinium-cluster-fullerene-conjugate: a new chance in cancer diagnostics | |
Chang et al. | Synthesis and characterization of a new bioactivated paramagnetic gadolinium (III) complex [Gd (DOTA-FPG)(H2O)] for tracing gene expression | |
HUE032152T2 (en) | Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri) | |
Tripepi et al. | Synthesis of high relaxivity gadolinium AAZTA tetramers as building blocks for bioconjugation | |
Martinelli et al. | Dendrimeric β‐Cyclodextrin/GdIII Chelate Supramolecular Host–Guest Adducts as High‐Relaxivity MRI Probes | |
Nonat et al. | New Bisaqua Picolinate‐Based Gadolinium Complexes as MRI Contrast Agents with Substantial High‐Field Relaxivities | |
Leygue et al. | Efficient synthesis of a family of bifunctional chelators based on the PCTA [12] macrocycle suitable for bioconjugation | |
Tei et al. | Target visualization by MRI using the avidin/biotin amplification route: synthesis and testing of a biotin–Gd‐DOTA monoamide trimer | |
Eggenspiller et al. | Design of Porphyrin‐dota‐Like Scaffolds as All‐in‐One Multimodal Heterometallic Complexes for Medical Imaging | |
Corsi et al. | Inulin as a carrier for contrast agents in magnetic resonance imaging | |
Leone et al. | Optimizing the relaxivity of MRI probes at high magnetic field strengths with binuclear GdIII complexes | |
Livramento et al. | A benzene-core trinuclear Gd III complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field | |
Avedano et al. | Maximizing the relaxivity of HSA-bound gadolinium complexes by simultaneous optimization of rotation and water exchange | |
Travagin et al. | AAZTA: The rise of mesocyclic chelating agents for metal coordination in medicine | |
Tietze et al. | New insight into the mode of action of nickel superoxide dismutase by investigating metallopeptide substrate models | |
Leone et al. | A neutral and stable macrocyclic Mn (II) complex for MRI tumor visualization | |
Desbois et al. | Synthetic strategy for preparation of a folate corrole DOTA heterobimetallic Cu–Gd complex as a potential bimodal contrast agent in medical imaging |